NYSE:BDX - Becton Dickinson Stock Price, Price Target & More

$233.02 +0.14 (+0.06 %)
(As of 04/23/2018 04:00 PM ET)
Previous Close$233.02
Today's Range$231.82 - $234.00
52-Week Range$175.66 - $248.39
Volume748,398 shs
Average Volume1.37 million shs
Market Capitalization$62.00 billion
P/E Ratio24.58
Dividend Yield1.28%
Beta1.15

About Becton Dickinson (NYSE:BDX)

Becton Dickinson logoBecton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. It operates in two segments, BD Medical and BD Life Sciences. The BD Medical segment offers syringes, pen needles, and other products for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laparoscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment provides integrated systems for specimen collection; safety-engineered blood collection, automated blood culturing and tuberculosis culturing, and microorganism identification and drug susceptibility systems; molecular testing systems for infectious diseases and women's health; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation and plated media products; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry, and general public. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Receive BDX News and Ratings via Email

Sign-up to receive the latest news and ratings for BDX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNYSE:BDX
CUSIP07588710
Phone201-847-6800

Debt

Debt-to-Equity Ratio1.04%
Current Ratio1.54%
Quick Ratio0.93%

Price-To-Earnings

Trailing P/E Ratio24.58
Forward P/E Ratio21.28
P/E Growth1.69

Sales & Book Value

Annual Sales$12.09 billion
Price / Sales5.13
Cash Flow$14.1139 per share
Price / Cash16.51
Book Value$56.89 per share
Price / Book4.10

Profitability

EPS (Most Recent Fiscal Year)$9.48
Net Income$1.10 billion
Net Margins2.71%
Return on Equity16.19%
Return on Assets5.74%

Miscellaneous

Employees41,933
Outstanding Shares266,240,000

How to Become a New Pot Stock Millionaire

Becton Dickinson (NYSE:BDX) Frequently Asked Questions

What is Becton Dickinson's stock symbol?

Becton Dickinson trades on the New York Stock Exchange (NYSE) under the ticker symbol "BDX."

How often does Becton Dickinson pay dividends? What is the dividend yield for Becton Dickinson?

Becton Dickinson announced a quarterly dividend on Monday, April 23rd. Shareholders of record on Friday, June 8th will be paid a dividend of $0.75 per share on Friday, June 29th. This represents a $3.00 dividend on an annualized basis and a yield of 1.29%. View Becton Dickinson's Dividend History.

How were Becton Dickinson's earnings last quarter?

Becton Dickinson (NYSE:BDX) posted its quarterly earnings results on Tuesday, February, 6th. The medical instruments supplier reported $2.48 earnings per share for the quarter, beating analysts' consensus estimates of $2.41 by $0.07. The medical instruments supplier had revenue of $3.08 billion for the quarter, compared to analyst estimates of $3.05 billion. Becton Dickinson had a return on equity of 16.19% and a net margin of 2.71%. The company's quarterly revenue was up 5.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.33 EPS. View Becton Dickinson's Earnings History.

When is Becton Dickinson's next earnings date?

Becton Dickinson is scheduled to release their next quarterly earnings announcement on Thursday, May, 3rd 2018. View Earnings Estimates for Becton Dickinson.

What guidance has Becton Dickinson issued on next quarter's earnings?

Becton Dickinson updated its FY18 earnings guidance on Tuesday, February, 6th. The company provided earnings per share (EPS) guidance of $10.85-11.00 for the period, compared to the Thomson Reuters consensus estimate of $10.88.

What price target have analysts set for BDX?

15 analysts have issued 12 month target prices for Becton Dickinson's stock. Their predictions range from $180.00 to $260.00. On average, they expect Becton Dickinson's stock price to reach $240.00 in the next year. View Analyst Ratings for Becton Dickinson.

Who are some of Becton Dickinson's key competitors?

Who are Becton Dickinson's key executives?

Becton Dickinson's management team includes the folowing people:
  • Mr. Vincent A. Forlenza, Chairman & CEO (Age 65)
  • Mr. Thomas E. Polen Jr., Pres (Age 45)
  • Mr. Christopher R. Reidy, Exec. VP, CFO & Chief Admin. Officer (Age 61)
  • Mr. Alexandre Conroy, Pres of Worldwide Medication & Procedural Solutions (Age 55)
  • Dr. Ellen R. Strahlman, Former Exec. VP of R&D and Chief Medical Officer (Age 61)

Has Becton Dickinson been receiving favorable news coverage?

News headlines about BDX stock have been trending somewhat positive recently, according to Accern. The research group identifies negative and positive press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Becton Dickinson earned a coverage optimism score of 0.12 on Accern's scale. They also assigned news stories about the medical instruments supplier an impact score of 45.99 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

How do I buy shares of Becton Dickinson?

Shares of BDX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Becton Dickinson's stock price today?

One share of BDX stock can currently be purchased for approximately $233.02.

How big of a company is Becton Dickinson?

Becton Dickinson has a market capitalization of $62.00 billion and generates $12.09 billion in revenue each year. The medical instruments supplier earns $1.10 billion in net income (profit) each year or $9.48 on an earnings per share basis. Becton Dickinson employs 41,933 workers across the globe.

How can I contact Becton Dickinson?

Becton Dickinson's mailing address is 1 BECTON DRIVE, FRANKLIN LAKES NJ, 07417. The medical instruments supplier can be reached via phone at 201-847-6800.


MarketBeat Community Rating for Becton Dickinson (BDX)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  344 (Vote Outperform)
Underperform Votes:  439 (Vote Underperform)
Total Votes:  783
MarketBeat's community ratings are surveys of what our community members think about Becton Dickinson and other stocks. Vote "Outperform" if you believe BDX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BDX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Becton Dickinson (NYSE:BDX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
15 Wall Street analysts have issued ratings and price targets for Becton Dickinson in the last 12 months. Their average twelve-month price target is $240.00, suggesting that the stock has a possible upside of 3.00%. The high price target for BDX is $260.00 and the low price target for BDX is $180.00. There are currently 4 hold ratings, 10 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.802.752.802.79
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
10 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
10 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
10 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
9 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $240.00$236.60$232.00$203.6154
Price Target Upside: 3.00% upside8.90% upside0.05% downside3.22% downside

Becton Dickinson (NYSE:BDX) Consensus Price Target History

Price Target History for Becton Dickinson (NYSE:BDX)

Becton Dickinson (NYSE:BDX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/10/2018CitigroupUpgradeNeutral -> Buy$237.00 -> $251.00LowView Rating Details
3/5/2018BMO Capital MarketsInitiated CoverageMarket Perform$249.00LowView Rating Details
2/7/2018Morgan StanleyBoost Price TargetEqual Weight -> Equal Weight$245.00 -> $250.00LowView Rating Details
2/6/2018Piper JaffrayReiterated RatingOverweight$223.00 -> $260.00LowView Rating Details
1/19/2018Bank of AmericaReiterated RatingBuy -> Buy$260.00MediumView Rating Details
1/5/2018KeyCorpInitiated CoverageOverweight -> Overweight$260.00LowView Rating Details
1/3/2018Evercore ISIInitiated CoverageOutperform -> Outperform$245.00MediumView Rating Details
12/29/2017Deutsche BankSet Price TargetBuy -> Buy$239.00 -> $260.00LowView Rating Details
12/14/2017ArgusBoost Price TargetAverage -> Buy$235.00LowView Rating Details
11/3/2017Stifel NicolausReiterated RatingBuy$245.00N/AView Rating Details
11/3/2017Royal Bank of CanadaReiterated RatingSector Perform -> Sector Perform$210.00 -> $230.00N/AView Rating Details
10/24/2017Wells FargoReiterated RatingOutperform -> Positive$225.00 -> $235.00N/AView Rating Details
8/14/2017CowenReiterated RatingBuy$230.00LowView Rating Details
8/10/2017BarclaysReiterated RatingEqual Weight$205.00 -> $210.00LowView Rating Details
6/30/2017Raymond JamesUpgradeOutperform -> Strong-Buy$210.00 -> $180.00LowView Rating Details
3/29/2017Jefferies GroupReiterated RatingBuy$200.00LowView Rating Details
1/5/2017UBSDowngradeStrong-Buy -> OutperformN/AView Rating Details
1/3/2017JPMorgan ChaseDowngradeOverweight -> Neutral$190.00 -> $175.00N/AView Rating Details
11/21/2016Leerink SwannReiterated RatingMarket Perform$180.00 -> $185.00N/AView Rating Details
(Data available from 4/23/2016 forward)

Earnings

Becton Dickinson (NYSE:BDX) Earnings History and Estimates Chart

Earnings by Quarter for Becton Dickinson (NYSE:BDX)

Becton Dickinson (NYSE:BDX) Earnings Estimates

2018 EPS Consensus Estimate: $10.75
2019 EPS Consensus Estimate: $12.72
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$2.28$2.28$2.28
Q2 20183$2.56$2.65$2.61
Q3 20183$2.80$2.98$2.86
Q4 20182$2.95$3.04$3.00
Q1 20192$2.97$3.05$3.01
Q2 20192$3.09$3.13$3.11
Q3 20192$3.22$3.31$3.27
Q4 20192$3.33$3.34$3.34

Becton Dickinson (NYSE BDX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/30/2018$2.62N/AView Earnings Details
2/6/2018Q1 2018$2.4090$2.48$3.0526 billion$3.08 billionViewListenView Earnings Details
11/2/2017Q4 2017$2.37$2.40$3.1439 billion$3.1660 billionViewN/AView Earnings Details
8/3/2017Q3 2017$2.44$2.46$3.0605 billion$3.0350 billionViewListenView Earnings Details
5/2/2017Q2 2017$2.23$2.30$2.9249 billion$2.9690 billionViewListenView Earnings Details
2/2/2017Q117$2.11$2.3320$2.86 billion$2.92 billionViewListenView Earnings Details
11/3/2016Q416$2.09$2.12$3.22 billion$3.23 billionViewListenView Earnings Details
8/4/2016Q316$2.20$2.35$3.21 billion$3.20 billionViewListenView Earnings Details
5/5/2016Q216$2.02$2.18$3.07 billion$3.07 billionViewListenView Earnings Details
2/3/2016Q116$1.84$1.96$3.04 billion$2.99 billionViewListenView Earnings Details
11/4/2015Q415$1.90$1.94$3.04 billion$3.07 billionViewListenView Earnings Details
8/6/2015Q315$2.01$2.05$3.13 billion$3.12 billionViewListenView Earnings Details
5/7/2015Q2$1.54$1.61$2.05 billion$2.05 billionViewListenView Earnings Details
2/5/2015Q115$1.43$1.53$2.04 billion$2.05 billionViewListenView Earnings Details
11/4/2014Q414$1.65$1.68$2.16 billion$2.20 billionViewListenView Earnings Details
7/31/2014Q314$1.68$1.68$2.14 billion$2.16 billionViewListenView Earnings Details
5/1/2014Q2$1.50$1.53$2.09 billion$2.07 billionViewListenView Earnings Details
2/4/2014Q114$1.30$1.42$1.98 billion$2.00 billionViewListenView Earnings Details
11/5/2013Q413$1.46$1.52$2.05 billion$2.10 billionViewListenView Earnings Details
8/1/2013Q3 2013$1.48$1.58$2.05 million$2.05 billionViewListenView Earnings Details
5/2/2013Q2 2013$1.35$1.44$1.99 billion$2.00 billionViewListenView Earnings Details
2/5/2013Q1 2013$1.24$1.35$1.86 billion$1.90 billionViewListenView Earnings Details
11/7/2012Q412$1.40$1.42$1.9628 billion$1.9670 billionViewN/AView Earnings Details
8/2/2012$1.53$1.52ViewN/AView Earnings Details
5/1/2012$1.38$1.38ViewN/AView Earnings Details
2/7/2012$1.17$1.21ViewN/AView Earnings Details
11/2/2011$1.41$1.39ViewN/AView Earnings Details
8/2/2011$1.43$1.53ViewN/AView Earnings Details
4/26/2011$1.30$1.38ViewN/AView Earnings Details
2/7/2011$1.29$1.35ViewN/AView Earnings Details
11/3/2010Q4 2010$1.25$1.24ViewN/AView Earnings Details
7/29/2010Q3 2010$1.25$1.29ViewN/AView Earnings Details
4/29/2010Q2 2010$1.23$1.24ViewN/AView Earnings Details
1/28/2010Q1 2010$1.20$1.30ViewN/AView Earnings Details
11/4/2009Q4 2009$1.24$1.25ViewN/AView Earnings Details
7/30/2009Q3 2009$1.24$1.30ViewN/AView Earnings Details
4/28/2009Q2 2009$1.16$1.18ViewN/AView Earnings Details
1/27/2009Q1 2009$1.16$1.26ViewN/AView Earnings Details
11/5/2008Q4 2008$1.12$1.13ViewN/AView Earnings Details
7/24/2008Q3 2008$1.10$1.18ViewN/AView Earnings Details
4/23/2008Q2 2008$1.04$1.09ViewN/AView Earnings Details
1/24/2008Q1 2008$1.03$1.07ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Becton Dickinson (NYSE:BDX) Dividend Information

Becton Dickinson pays an annual dividend of $3.00 per share, with a dividend yield of 1.29%. BDX's next quarterly dividend payment will be made on Friday, June 29. The company has grown its dividend for the last 46 consecutive years and is increasing its dividend by an average of 9.60% each year. Becton Dickinson pays out 31.65% of its earnings out as a dividend.
Next Dividend:6/29/2018
Annual Dividend:$3.00
Dividend Yield:1.29%
Dividend Growth:9.60% (3 Year Average)
Payout Ratio:31.65% (Trailing 12 Months of Earnings)
27.40% (Based on This Year's Estimates)
23.75% (Based on Next Year's Estimates)
Track Record:46 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Becton Dickinson (NYSE:BDX)

Becton Dickinson (NYSE:BDX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/23/2018quarterly$0.751.29%6/8/20186/29/2018
1/22/2018quarterly$0.751.38%3/8/20183/9/20183/30/2018
11/20/2017quarterly$0.751.32%12/7/201712/8/201712/29/2017
7/25/2017quarterly$0.731.44%9/7/20179/8/20179/29/2017
5/23/2017quarterly$0.731.56%6/7/20176/9/20176/30/2017
1/23/2017quarterly$0.731.71%3/8/20173/10/20173/31/2017
11/21/2016quarterly$0.731.74%12/7/201612/9/201612/30/2016
7/26/2016quarterly$0.661.51%9/7/20169/9/20169/30/2016
5/24/2016quarterly$0.661.58%6/7/20166/9/20166/30/2016
1/25/2016quarterly$0.661.81%3/8/20163/10/20163/31/2016
11/23/2015quarterly$0.661.75%12/8/201512/10/201512/31/2015
7/28/2015quarterly$0.601.58%9/4/20159/9/20159/30/2015
5/19/2015quarterly$0.601.69%6/5/20156/9/20156/30/2015
1/27/2015quarterly$0.601.65%3/6/20153/10/20153/31/2015
11/25/2014quarterly$0.601.7%12/8/201412/10/201412/31/2014
7/22/2014quarterly$0.54501.84%9/5/20149/9/20149/30/2014
5/20/2014quarterly$0.54501.88%6/5/20146/9/20146/30/2014
1/28/2014quarterly$0.54502.02%3/6/20143/10/20143/31/2014
11/26/2013quarterly$0.54502%12/6/201312/10/201312/31/2013
7/23/2013quarterly$0.49501.91%9/5/20139/9/20139/30/2013
5/21/2013quarterly$0.49501.98%6/5/20136/7/20136/28/2013
1/29/2013quarterly$0.49502.35%3/6/20133/8/20133/29/2013
(Data available from 1/1/2013 forward)

Insider Trades

Becton Dickinson (NYSE BDX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.00%
Institutional Ownership Percentage: 83.62%
Insider Trading History for Becton Dickinson (NYSE:BDX)
Institutional Ownership by Quarter for Becton Dickinson (NYSE:BDX)

Becton Dickinson (NYSE BDX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/13/2018Thomas E Polen JrEVPSell1,877$227.00$426,079.0015,387View SEC Filing  
2/27/2018John E GallagherVPSell5,346$226.08$1,208,623.689,391View SEC Filing  
2/26/2018James W BorziEVPSell4,048$224.98$910,719.045,334View SEC Filing  
2/23/2018Timothy M RingDirectorSell176$218.27$38,415.52170,688View SEC Filing  
2/8/2018Timothy M RingDirectorSell269,661$217.82$58,737,559.02295,753View SEC Filing  
9/11/2017Gary M CohenInsiderSell15,512$203.77$3,160,880.2495,781View SEC Filing  
9/8/2017Stephen SichakInsiderSell11,787$200.46$2,362,822.0214,038View SEC Filing  
8/22/2017Gary M CohenInsiderSell15,044$200.43$3,015,268.9295,270View SEC Filing  
8/22/2017Linda M TharbyEVPSell4,695$200.48$941,253.6018,670View SEC Filing  
8/15/2017Nabil ShabshabInsiderSell6,149$201.76$1,240,622.2415,648View SEC Filing  
8/14/2017Ribo Alberto MasEVPSell7,463$201.41$1,503,122.8329,323View SEC Filing  
8/10/2017Ellen R StrahlmanInsiderSell9,283$198.21$1,839,983.4326,638View SEC Filing  
8/9/2017Thomas E Polen JrInsiderSell5,971$197.41$1,178,735.1112,861View SEC Filing  
5/25/2017Jeffrey S ShermanVPSell28,765$185.98$5,349,714.7070,821View SEC Filing  
2/15/2017Jeffrey S ShermanVPSell31,464$180.02$5,664,149.2822,094View SEC Filing  
12/15/2016John E GallagherVPSell1,793$168.82$302,694.262,796View SEC Filing  
12/5/2016Stephen SichakInsiderSell2,632$164.44$432,806.087,953View SEC Filing  
11/4/2016Stephen SichakInsiderSell10,352$176.10$1,822,987.2026,892View SEC Filing  
9/6/2016Linda M TharbyInsiderSell11,704$177.27$2,074,768.0822,146View SEC Filing  
8/11/2016Gary M CohenInsiderSell29,367$176.81$5,192,379.27125,870View SEC Filing  
6/13/2016John E GallagherVPSell1,931$169.87$328,018.976,758View SEC Filing  
6/7/2016Nabil ShabshabEVPSell5,080$168.75$857,250.0011,092View SEC Filing  
5/17/2016Jeffrey S ShermanVPSell34,373$166.27$5,715,198.7149,736View SEC Filing  
5/13/2016Stephen SichakEVPSell12,995$166.48$2,163,407.6031,561View SEC Filing  
5/13/2016Vincent A ForlenzaCEOSell37,933$166.17$6,303,326.61207,225View SEC Filing  
5/10/2016James F OrrDirectorSell1,368$167.66$229,358.8823,045View SEC Filing  
5/9/2016James C LimEVPSell5,257$165.60$870,559.2012,556View SEC Filing  
5/6/2016Ellen R StrahlmanSVPSell3,019$163.52$493,666.887,218View SEC Filing  
5/6/2016Jerome V HurwitzEVPSell3,878$163.58$634,363.243,027View SEC Filing  
5/6/2016Rebecca W RimelDirectorSell684$163.69$111,963.966,835View SEC Filing  
12/14/2015Stephen SichakEVPSell8,670$152.21$1,319,660.708,646View SEC Filing  
12/9/2015William A KozyEVPSell15,495$154.43$2,392,892.8568,823View SEC Filing  
12/8/2015Vincent A. ForlenzaCEOSell17,762$153.10$2,719,362.20172,681View SEC Filing  
12/7/2015Jeffrey S ShermanVPSell7,586$153.76$1,166,423.3623,734View SEC Filing  
12/1/2015Thomas E Polen JrEVPSell2,683$152.21$408,379.435,789View SEC Filing  
11/30/2015John E GallagherVPSell1,600$150.70$241,120.003,393View SEC Filing  
11/18/2015Jerome V. HurwitzEVPSell2,347$151.02$354,443.944,866View SEC Filing  
6/1/2015Stephen SichakEVPSell12,188$140.94$1,717,776.72View SEC Filing  
5/22/2015Thomas E Polen JrEVPSell3,882$142.56$553,417.92View SEC Filing  
5/21/2015Linda M TharbyEVPSell6,069$142.02$861,919.38View SEC Filing  
5/20/2015William A KozyEVPSell10,326$142.00$1,466,292.00View SEC Filing  
5/19/2015William A KozyEVPSell10,435$142.01$1,481,874.35View SEC Filing  
5/18/2015Bertram L ScottDirectorSell2,160$141.74$306,158.40View SEC Filing  
5/18/2015James C LimEVPSell3,604$141.80$511,047.20View SEC Filing  
5/15/2015Alexandre ConroyEVPSell1,291$141.37$182,508.67View SEC Filing  
5/13/2015Jeffrey S ShermanVPSell10,983$138.40$1,520,047.20View SEC Filing  
5/11/2015Jerome V HurwitzEVPSell1,197$141.43$169,291.71View SEC Filing  
5/8/2015Gary M CohenEVPSell13,490$142.90$1,927,721.00View SEC Filing  
6/12/2014Stephen SichakSVPSell1,456$118.25$172,172.00View SEC Filing  
6/10/2014Gary M CohenEVPSell12,476$119.24$1,487,638.24View SEC Filing  
6/9/2014Jeffrey S ShermanVPSell7,877$120.24$947,130.48View SEC Filing  
3/6/2014Jeffrey ShermanVPSell1,303$115.16$150,053.4827,768View SEC Filing  
11/12/2013William KozyEVPSell9,597$108.30$1,039,355.10101,090View SEC Filing  
11/11/2013Jeffrey ShermanVPSell4,272$107.78$460,436.1625,176View SEC Filing  
11/11/2013Jerome HurwitzSVPSell1,151$107.78$124,054.781,687View SEC Filing  
11/8/2013Vincent ForlenzaCEOSell32,411$107.39$3,480,617.29108,724View SEC Filing  
11/6/2013Henry Becton, Jr.DirectorSell2,276$106.77$243,008.5223,820View SEC Filing  
8/23/2013Bertram ScottDirectorSell4,047$98.61$399,074.6720,768View SEC Filing  
8/8/2013Edward DegraanDirectorSell4,436$100.03$443,733.0818,608View SEC Filing  
8/8/2013Stephen SichakSVPSell3,431$100.13$343,546.036,297View SEC Filing  
8/7/2013Basil AndersonDirectorSell2,160$99.79$215,546.4017,221View SEC Filing  
5/22/2013Henry P Becton JrDirectorSell3,117$101.86$317,497.62View SEC Filing  
5/17/2013Donna M BolesVPSell2,415$101.38$244,832.70View SEC Filing  
5/13/2013Gary M CohenEVPSell8,753$100.22$877,225.66View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Becton Dickinson (NYSE BDX) News Headlines

Source:
DateHeadline
Becton Dickinson Declares Quarterly Dividend of $0.75 (BDX)Becton Dickinson Declares Quarterly Dividend of $0.75 (BDX)
www.americanbankingnews.com - April 23 at 6:54 PM
Can BD Medical Drive Becton, Dickinsons (BDX) Q2 Earnings?Can BD Medical Drive Becton, Dickinson's (BDX) Q2 Earnings?
www.zacks.com - April 23 at 5:11 PM
BD Board Declares DividendsBD Board Declares Dividends
finance.yahoo.com - April 23 at 5:11 PM
Becton Dickinson (BDX) Scheduled to Post Quarterly Earnings on MondayBecton Dickinson (BDX) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - April 23 at 4:12 AM
Head to Head Comparison: Becton Dickinson (BDX) vs. Its RivalsHead to Head Comparison: Becton Dickinson (BDX) vs. Its Rivals
www.americanbankingnews.com - April 22 at 1:20 PM
BidaskClub Upgrades Becton Dickinson (BDX) to Strong-BuyBidaskClub Upgrades Becton Dickinson (BDX) to Strong-Buy
www.americanbankingnews.com - April 19 at 1:58 PM
Becton Dickinson and (BDX) Upgraded by ValuEngine to BuyBecton Dickinson and (BDX) Upgraded by ValuEngine to Buy
www.americanbankingnews.com - April 18 at 1:56 PM
Becton Dickinson and (BDX) Raised to Buy at Zacks Investment ResearchBecton Dickinson and (BDX) Raised to Buy at Zacks Investment Research
www.americanbankingnews.com - April 17 at 10:55 PM
BidaskClub Downgrades Becton Dickinson and (BDX) to BuyBidaskClub Downgrades Becton Dickinson and (BDX) to Buy
www.americanbankingnews.com - April 15 at 12:05 AM
Becton Dickinson and (BDX) Earns Buy Rating from Stifel NicolausBecton Dickinson and (BDX) Earns Buy Rating from Stifel Nicolaus
www.americanbankingnews.com - April 12 at 1:13 PM
Global Flow Cytometry Market Opportunities 2018: Dickinson and Company, Becton, Agilent Technologies, Miltenyi BiotecGlobal Flow Cytometry Market Opportunities 2018: Dickinson and Company, Becton, Agilent Technologies, Miltenyi Biotec
www.marketwatch.com - April 11 at 8:34 AM
 Analysts Expect Becton Dickinson and Co (BDX) Will Announce Quarterly Sales of $4.12 Billion Analysts Expect Becton Dickinson and Co (BDX) Will Announce Quarterly Sales of $4.12 Billion
www.americanbankingnews.com - April 11 at 7:45 AM
Becton Dickinson and (BDX) Receives Equal Weight Rating from BarclaysBecton Dickinson and (BDX) Receives Equal Weight Rating from Barclays
www.americanbankingnews.com - April 10 at 8:24 PM
UPDATE: Citi Upgrades Becton Dickinson (BDX) to BuyUPDATE: Citi Upgrades Becton Dickinson (BDX) to Buy
www.streetinsider.com - April 10 at 5:27 PM
Citi Projects 16% Upside For Becton Dickinson In UpgradeCiti Projects 16% Upside For Becton Dickinson In Upgrade
finance.yahoo.com - April 10 at 5:27 PM
Becton Dickinson and (BDX) Stock Rating Upgraded by BidaskClubBecton Dickinson and (BDX) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - April 10 at 4:29 PM
Becton Dickinson and (BDX) Upgraded to Buy at CitigroupBecton Dickinson and (BDX) Upgraded to Buy at Citigroup
www.americanbankingnews.com - April 10 at 8:47 AM
Global Blood Testing Market Opportunities 2018: Bio-Rad Laboratories, Becton Dickinson & Company, Roche Diagnostics, Novartis DiagnosticsGlobal Blood Testing Market Opportunities 2018: Bio-Rad Laboratories, Becton Dickinson & Company, Roche Diagnostics, Novartis Diagnostics
www.marketwatch.com - April 9 at 8:24 AM
$2.60 EPS Expected for Becton Dickinson and Co (BDX) This Quarter$2.60 EPS Expected for Becton Dickinson and Co (BDX) This Quarter
www.americanbankingnews.com - April 9 at 1:26 AM
Becton Dickinson and (BDX) Stock Rating Reaffirmed by Wells FargoBecton Dickinson and (BDX) Stock Rating Reaffirmed by Wells Fargo
www.americanbankingnews.com - April 5 at 9:36 PM
Varian’s HyperArc: Driven by Rising Metastatic Brain Cancer?Varian’s HyperArc: Driven by Rising Metastatic Brain Cancer?
finance.yahoo.com - April 5 at 10:16 AM
See what the IHS Markit Score report has to say about Becton Dickinson and Co.See what the IHS Markit Score report has to say about Becton Dickinson and Co.
finance.yahoo.com - April 4 at 4:10 PM
Transradial Access Market 2018 - Global Forecast 2022: Becton, Dickinson and Company (US) and Terumo ...Transradial Access Market 2018 - Global Forecast 2022: Becton, Dickinson and Company (US) and Terumo ...
www.businesswire.com - April 4 at 8:24 AM
BD Announces Live Webcast Of Second Fiscal Quarter Earnings Conference CallBD Announces Live Webcast Of Second Fiscal Quarter Earnings Conference Call
finance.yahoo.com - April 3 at 5:32 PM
Global Needles Market Opportunities 2018: Dickinson and Company (BD), Becton, Unilife Corp, Terumo CorporationGlobal Needles Market Opportunities 2018: Dickinson and Company (BD), Becton, Unilife Corp, Terumo Corporation
www.marketwatch.com - April 3 at 8:27 AM
A Look at BDX’s Recent Launch and Its ApplicationsA Look at BDX’s Recent Launch and Its Applications
finance.yahoo.com - April 2 at 8:43 AM
Becton Dickinson and Co (BDX) Receives Consensus Recommendation of "Buy" from AnalystsBecton Dickinson and Co (BDX) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - March 31 at 8:11 AM
Becton Dickinson and (BDX) Research Coverage Started at Evercore ISIBecton Dickinson and (BDX) Research Coverage Started at Evercore ISI
www.americanbankingnews.com - March 30 at 11:42 PM
Zacks Investment Research Upgrades Becton Dickinson and (BDX) to "Buy"Zacks Investment Research Upgrades Becton Dickinson and (BDX) to "Buy"
www.americanbankingnews.com - March 30 at 11:10 PM
BDX Divests Its Remaining Stake in Vyaire to Apax PartnersBDX Divests Its Remaining Stake in Vyaire to Apax Partners
finance.yahoo.com - March 30 at 5:28 PM
Trade War Fears Triggered Medtronic’s Stock Decline on March 23Trade War Fears Triggered Medtronic’s Stock Decline on March 23
finance.yahoo.com - March 27 at 5:11 PM
A Look at Medtronic’s Technical IndicatorsA Look at Medtronic’s Technical Indicators
finance.yahoo.com - March 27 at 5:11 PM
$4.12 Billion in Sales Expected for Becton Dickinson and Co (BDX) This Quarter$4.12 Billion in Sales Expected for Becton Dickinson and Co (BDX) This Quarter
www.americanbankingnews.com - March 24 at 1:44 AM
BD Updates Instructions for Use for Certain BD Vacutainer® Blood ... - PR Newswire (press release)BD Updates Instructions for Use for Certain BD Vacutainer® Blood ... - PR Newswire (press release)
www.prnewswire.com - March 23 at 8:23 AM
Becton Dickinson and Co (BDX) Expected to Announce Earnings of $2.60 Per ShareBecton Dickinson and Co (BDX) Expected to Announce Earnings of $2.60 Per Share
www.americanbankingnews.com - March 22 at 11:06 PM
BRIEF-Becton Dickinson Updates Instructions for Use for Certain BD Vacutainer Blood Collection TubesBRIEF-Becton Dickinson Updates Instructions for Use for Certain BD Vacutainer Blood Collection Tubes
www.reuters.com - March 22 at 5:33 PM
BD Updates Instructions for Use for Certain BD Vacutainer® Blood Collection TubesBD Updates Instructions for Use for Certain BD Vacutainer® Blood Collection Tubes
finance.yahoo.com - March 22 at 5:33 PM
Becton Dickinson (BDX) to Divest Remaining Investment in Vyaire MedicalBecton Dickinson (BDX) to Divest Remaining Investment in Vyaire Medical
www.streetinsider.com - March 20 at 5:14 PM
William Blair Weighs in on Becton Dickinson and Cos FY2018 Earnings (BDX)William Blair Weighs in on Becton Dickinson and Co's FY2018 Earnings (BDX)
www.americanbankingnews.com - March 20 at 9:00 AM
[$$] Apax Buying Remaining Stake in Vyaire Medical for $435 Million[$$] Apax Buying Remaining Stake in Vyaire Medical for $435 Million
finance.yahoo.com - March 19 at 5:15 PM
BD to Divest Remaining Investment in Vyaire Medical to Funds Managed by Apax PartnersBD to Divest Remaining Investment in Vyaire Medical to Funds Managed by Apax Partners
www.prnewswire.com - March 19 at 12:01 PM
Funds advised by Apax Partners to acquire remaining minority stake in Vyaire Medical from BDFunds advised by Apax Partners to acquire remaining minority stake in Vyaire Medical from BD
www.prnewswire.com - March 19 at 12:01 PM
Becton Dickinson and Co (BDX) EVP Thomas E. Polen, Jr. Sells 1,877 SharesBecton Dickinson and Co (BDX) EVP Thomas E. Polen, Jr. Sells 1,877 Shares
www.americanbankingnews.com - March 14 at 10:18 AM
Cigna to Take Over Express Scripts (ESRX) for $67 Billion - NasdaqCigna to Take Over Express Scripts (ESRX) for $67 Billion - Nasdaq
www.nasdaq.com - March 13 at 8:29 AM
Becton, Dickinson (BDX) Down 1.3% Since Last Earnings ReportBecton, Dickinson (BDX) Down 1.3% Since Last Earnings Report
finance.yahoo.com - March 8 at 6:36 PM
BD to Present at the Barclays Global Healthcare ConferenceBD to Present at the Barclays Global Healthcare Conference
finance.yahoo.com - March 8 at 6:36 PM
Becton, Dickinson and Company (BDX) Ex-Dividend Date Scheduled for March 08, 2018 - NasdaqBecton, Dickinson and Company (BDX) Ex-Dividend Date Scheduled for March 08, 2018 - Nasdaq
www.nasdaq.com - March 8 at 8:27 AM
Ex-Dividend Reminder: Becton, Dickinson, Hanover Insurance Group and Anthem - NasdaqEx-Dividend Reminder: Becton, Dickinson, Hanover Insurance Group and Anthem - Nasdaq
www.nasdaq.com - March 7 at 8:23 AM
Becton Dickinson and (BDX) Cut to "Hold" at Zacks Investment ResearchBecton Dickinson and (BDX) Cut to "Hold" at Zacks Investment Research
www.americanbankingnews.com - March 6 at 5:16 PM
Becton Dickinson and Co (BDX) Shares Sold by Peak Asset Management LLCBecton Dickinson and Co (BDX) Shares Sold by Peak Asset Management LLC
www.americanbankingnews.com - March 6 at 2:54 PM

SEC Filings

Becton Dickinson (NYSE:BDX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Becton Dickinson (NYSE:BDX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Becton Dickinson (NYSE BDX) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.